Denise J. Pearson
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (1993–1997); University of Denver (2011); Children's Hospital of Philadelphia (2014–2016); Penn Presbyterian Medical Center (2009–2022); Purdue University West Lafayette (1996); Wright-Patterson Air Force Base (2019); University of the Arts (2013); California University of Pennsylvania (2011); University of Pennsylvania (2010–2022)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Denise J. Pearson's research has focused on multiple areas within medical science, including retinal degenerations and neonatal health outcomes. Her work on choroideremia has investigated the natural history of structural abnormalities and explored potential gene therapy delivery methods.
Pearson has also been involved in studies examining the effects of medical interventions on premature infants. This includes research on transfusions and neurodevelopmental outcomes in extremely low gestational age neonates, as well as the impact of erythropoietin on kidney-related outcomes in this population. Her publications also address the safety of retinopathy of prematurity examinations and imaging in premature infants, and the use of chronic peritoneal dialysis and hemofiltration in children with renal failure.
Her research metrics include an h-index of 16, with 43 total publications and 691 total citations. She has been recently active, with her most recent publication in 2023.
Metrics
- h-index: 16
- Publications: 43
- Citations: 691
Selected Publications
-
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates (2023)
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns (2022)
-
Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial (2021)
-
Use of pump-assisted hemofiltration in children with acute renal failure (1997)
-
Pump-assisted hemofiltration in infants with acute renal failure (1993)
Collaboration Network
Top Collaborators
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Use of pump-assisted hemofiltration in children with acute renal failure
- Pump-assisted hemofiltration in infants with acute renal failure
- Use of pump-assisted hemofiltration in children with acute renal failure
- Pump-assisted hemofiltration in infants with acute renal failure
- Use of pump-assisted hemofiltration in children with acute renal failure
- Pump-assisted hemofiltration in infants with acute renal failure
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Similar Researchers
Based on overlapping research topics